Confirmed Control Announced Transaction verified Acne careCPGDermatology skincareSkin Care

CeraVe, AcneFree, Ambi acquired by L'Oréal

L'Oréal agreed to acquire CeraVe, AcneFree, Ambi, a skincare brand, on Jan 10, 2017.

Transaction summary

Target
CeraVe, AcneFree, Ambi
Announced
2017-01-10
Geography
-
Type
Acquisition
Deal type
Control
Stake acquired
-
First added
2026-06-15
Latest update
2026-10-21

Parties at the deal date

Acquirer

L'Oréal

Current investor profile →

L'Oréal BOLD (Business Opportunities for L'Oréal Development) is L'Oréal's corporate venture capital fund, investing in startups across the beauty value chain including beauty brands, platforms, technology, and science for beauty.

Snapshot preserved for this transaction; current company profiles may differ.

Value and multiples

100% enterprise value

USD 1.3B

100% enterprise value | USD

Basis: FundComb estimate

Reported price is assumed to be 100% EV unless stated otherwise. Partial-stake estimates are qualified in the basis notes.

EV / revenue

7.7x

Period not stated

Basis: FundComb estimate

EV / EBITDA

-

EBITDA basis not stated

Basis: FundComb estimate

Basis

  • FundComb’s comps spreadsheet values CeraVe, AcneFree and Ambi at USD 1,300m, used as the whole-company enterprise value, with revenue of USD 169m: 7.7x revenue. The revenue period is not stated. These are FundComb estimates, not confirmed by a public source. Mass Market Retailers reported on 10 January 2017 that L’Oréal bought the three brands from Valeant.

Source summary

L’Oréal buys CeraVe, AcneFree, Ambi brands from Valeant - Mass Market Retailers

Confirmed
Open via Google News

Continue your research

Explore more comps →